Quoin Pharmaceuticals Ltd. (QNRX) stock
QNRXNasdaqPharmaceutical Preparations
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)
Close on Nov 18, 2026Market cap $7.15MP/E –Yield –
Quoin Pharmaceuticals EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2021 it was -$0.01.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -$0.01 | – |
| FY2020 | Dec 31, 2020 | -$0.70 | – |
| FY2019 | Dec 31, 2019 | -$0.52 | -812.3% |
| FY2017 | Dec 31, 2017 | $0.07 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?